Colon Cancer
818
113
164
364
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
99 trials with published results (12%)
Research Maturity
364 completed trials (44% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.1%
66 terminated out of 818 trials
84.7%
-1.9% vs benchmark
7%
60 trials in Phase 3/4
27%
99 of 364 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 364 completed trials
Clinical Trials (818)
Adaptive Symptom Self-Management Immunotherapy Study
Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)
Learning Curve of SILS in CRC
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer
Genomic Services Research Program
Collection of Blood From Patients With Cancer
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Predictors of Rescue Surgery, Mortality, and Permanent Stoma After Anastomotic Leak Following Colorectal Cancer Resection
COLOFLOW: Laser Speckle Contrast Imaging Versus Near-infrared Fluorescence Imaging With Indocyanine Green
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
Neoadjuvant Immunotherapy for T4 dMMR Colon Cancer
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Chronic Loose Stools Following Right-sided Hemicolectomy for Colon Cancer and the Association With Bile Acid Malabsorption and Small Intestinal Bacterial Overgrowth Using a Novel Sampling Device
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
ctDNA and TEP Levels in Colon Cancer
Frequency of Care for Peripherally Inserted Central Vascular Access In the Prevention of Marsi
Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors
Project HERO: Health Empowerment & Recovery Outcomes